UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 511

Sortiert nach

Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study

Clinical cancer research, 2015-02, Vol.21 (4), p.756-762

2015

Volltextzugriff (PDF)

Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database

Cancer causes & control, 2018-06, Vol.29 (6), p.581-588

2018

Volltextzugriff (PDF)

Predictors of Time to Metastasis in Castration-resistant Prostate Cancer

Urology (Ridgewood, N.J.), 2016-10, Vol.96, p.171-176

2016

Volltextzugriff (PDF)

Obesity, risk of biochemical recurrence, and prostate‐specific antigen doubling time after radical prostatectomy: results from the SEARCH database

BJU international, 2019-07, Vol.124 (1), p.69-75

2019

Volltextzugriff (PDF)

Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial

BJU international, 2020-02, Vol.125 (2), p.226-233

2020

Volltextzugriff (PDF)

Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical Recurrence

Urology (Ridgewood, N.J.), 2017-10, Vol.108, p.129-134

2017

Volltextzugriff (PDF)

Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

BJU international, 2014-11, Vol.114 (5), p.661-666

2014

Volltextzugriff (PDF)

Metabolic syndrome‐like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

BJU international, 2015-05, Vol.115 (5), p.736-743

2015

Volltextzugriff (PDF)

Nocturia and associated mortality: observational data from the REDUCE trial

Prostate cancer and prostatic diseases, 2019-03, Vol.22 (1), p.77-83

2019

Volltextzugriff (PDF)

Socioeconomic status, race, and long-term outcomes after radical prostatectomy in an equal access health system: Results from the SEARCH database

Urologic oncology, 2019-04, Vol.37 (4), p.289.e11-289.e17

2019

Volltextzugriff (PDF)

UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression

BMC cancer, 2017-07, Vol.17 (1), p.463-463, Article 463

2017

Volltextzugriff (PDF)

Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCH

International journal of urology, 2020-10, Vol.27 (10), p.851-857

2020

Volltextzugriff (PDF)

Response to Editorial Comment to Predictors of operative time during radical retropubic prostatectomy and robot‐assisted laparoscopic prostatectomy

International journal of urology, 2017-08, Vol.24 (8), p.624-625

2017

Volltextzugriff (PDF)

Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study

International journal of urology, 2017-02, Vol.24 (2), p.151-156

2017

Volltextzugriff (PDF)

Predictors of operative time during radical retropubic prostatectomy and robot‐assisted laparoscopic prostatectomy

International journal of urology, 2017-08, Vol.24 (8), p.618-623

2017

Volltextzugriff (PDF)

Impact of prior local therapy on overall survival in men with metastatic castration‐resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital

International journal of urology, 2018-12, Vol.25 (12), p.998-1004

2018

Volltextzugriff (PDF)

The association between sexual function and prostate cancer risk in US veterans

Asian journal of andrology, 2017-03, Vol.19 (2), p.191-195

2017

Volltextzugriff (PDF)

Adverse pathology and undetectable ultrasensitive prostate‐specific antigen after radical prostatectomy: is adjuvant radiation warranted?

BJU international, 2016-06, Vol.117 (6), p.897-903

2016

Volltextzugriff (PDF)

Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database

International journal of urology, 2015-04, Vol.22 (4), p.362-366

2015

Volltextzugriff (PDF)

Functional nasal morphology of chimaerid fishes

Journal of morphology (1931), 2013-09, Vol.274 (9), p.987-1009

2013

Volltextzugriff (PDF)

Characterization of a “low‐risk” cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database

International journal of urology, 2017-08, Vol.24 (8), p.611-617

2017

Volltextzugriff (PDF)

A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2)

Clinical cancer research, 2020-06, Vol.26 (12), p.3035-3043

2020

Volltextzugriff (PDF)

Obesity, race, and long‐term prostate cancer outcomes

Cancer, 2020-08, Vol.126 (16), p.3733-3741

2020

Volltextzugriff (PDF)

Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study

Cancer epidemiology, biomarkers & prevention, 2014-12, Vol.23 (12), p.2936-2942

2014

Volltextzugriff (PDF)

Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database

Cancer epidemiology, biomarkers & prevention, 2014-11, Vol.23 (11), p.2349-2356

2014

Volltextzugriff (PDF)

1 – 25 von 511

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(491)
Mit Volltextzugriff
(443)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study

Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database

Predictors of Time to Metastasis in Castration-resistant Prostate Cancer

Obesity, risk of biochemical recurrence, and prostate‐specific antigen doubling time after radical prostatectomy: results from the SEARCH database

Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial

Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical Recurrence

Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

Metabolic syndrome‐like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

Nocturia and associated mortality: observational data from the REDUCE trial

Socioeconomic status, race, and long-term outcomes after radical prostatectomy in an equal access health system: Results from the SEARCH database

UDP-glucuronosyltransferases and biochemical recurrence in prostate cancer progression

Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCH

Response to Editorial Comment to Predictors of operative time during radical retropubic prostatectomy and robot‐assisted laparoscopic prostatectomy

Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study

Predictors of operative time during radical retropubic prostatectomy and robot‐assisted laparoscopic prostatectomy

Impact of prior local therapy on overall survival in men with metastatic castration‐resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital

The association between sexual function and prostate cancer risk in US veterans

Adverse pathology and undetectable ultrasensitive prostate‐specific antigen after radical prostatectomy: is adjuvant radiation warranted?

Prostate-specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database

Functional nasal morphology of chimaerid fishes

Characterization of a “low‐risk” cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database

A Randomized Controlled Trial of a 6-Month Low-Carbohydrate Intervention on Disease Progression in Men with Recurrent Prostate Cancer: Carbohydrate and Prostate Study 2 (CAPS2)

Obesity, race, and long‐term prostate cancer outcomes

Obesity increases the risk for high-grade prostate cancer: results from the REDUCE study

Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database

Suchergebnisse filtern